Recent development in carbohydrate-based cancer vaccines.
about
Biosynthesis of rare hexoses using microorganisms and related enzymesStrategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen ModificationCarbohydrate-mimetic peptides for pan anti-tumor responsesAnti-idiotypic antibodies as cancer vaccines: achievements and future improvementsSynthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriersApplications of mass spectrometry to structural analysis of marine oligosaccharides.Antibody recognition of fluorinated MUC1 glycopeptide antigens.Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Translating tumor antigens into cancer vaccinesThe immunomodulating roles of glycoproteins in epithelial ovarian cancer.Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine CandidatesCancer vaccines and carbohydrate epitopes.Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Tumor-Associated Glycans and Immune SurveillancePathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodiesSignificant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.Chemoenzymatic synthesis of mono- and di-fluorinated Thomsen-Friedenreich (T) antigens and their sialylated derivatives.Chemical probing of glycans in cells and organismsBoosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma.From antimicrobial to anticancer peptides. A review.Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy.Carbohydrate-based vaccines: challenges and opportunities.Toward automated oligosaccharide synthesis.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.The sweet side of tumor immunotherapy.Glycopolymers and glyco-nanoparticles in biomolecular recognition processes and vaccine development.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances.A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines.Iron oxide superparamagnetic nanoparticles conjugated with a conformationally blocked α-Tn antigen mimetic for macrophage activation.Progress in the synthesis and biological evaluation of lipid A and its derivatives.Metabolic engineering pathways for rare sugars biosynthesis, physiological functionalities, and applications-a review.Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
P2860
Q26826944-B141AF25-B5E9-4265-9CE0-EA84E6C14DA0Q27001592-271CAE6F-2E78-4099-BCF0-A36EB6866D2CQ27023624-B671530B-D333-4C80-AFAA-A0DA7992CA81Q28278814-1AF05C05-8570-43B5-833F-378212AB7624Q33819711-F1ACED97-43B6-4F25-BC59-1888E92B4E55Q33963549-8945937F-C4FA-42E2-8490-B0AE56445F33Q34045866-BC1A1251-5116-4AD0-B3E0-1334A88F072BQ34478719-DCBB5A3A-18D6-4FB2-99A1-5A2E2B071B8AQ34484042-120E8D8F-90DE-49A2-B692-978A18A95BB7Q35077893-CF4FAB39-9ADF-452F-8F80-76FA7646D570Q35212122-6A837388-4697-4145-B578-56A2AE45CD1FQ35525289-6CB080AD-A3F9-47DC-BE4C-A63841C80D7EQ35705462-29584555-5EBA-49F2-96A5-0AF22F83E391Q35890610-AF985B96-7419-47E1-884D-F28B97E81DEEQ36328299-F55F5D08-09D6-4E76-B1E2-2413447ED3ABQ36340501-9E212866-1AB8-4885-B38E-58E860262517Q36497647-0EE3AF51-CA01-43DF-B982-FD480C0FEA41Q36501284-06D6EBC0-EB29-429D-9680-75B798B8ADD3Q36604334-8C032800-7C68-406E-A871-6BE6C1106E63Q36740938-991F104F-893A-4E4D-BE03-623EAC55DDB1Q36811051-E25E1810-A7AE-4299-8F0F-B7C204D426C3Q37076109-3DD3E45F-34D5-45B8-8C48-D8E3BD51BB48Q37100578-DC9709BB-8B7B-4942-8076-A56BFF9AD163Q37207728-E299D938-B42E-4A84-A59E-C7F3487C2200Q37418500-333A65B8-2C27-42E6-BA1E-10B385DDEC86Q37810597-6E7F8B10-6FBC-41C6-A565-C14407E13F9CQ37962848-E85271FA-BE55-4DBA-9AFB-7B7D226AD829Q37993590-9B5C03C1-75DE-4B92-AF54-92CCE6E5F612Q38016342-148F327F-623D-4149-8C70-B7E968E70299Q38031282-381E291E-6731-4483-AE18-81700CBA056DQ38050110-2FA66A48-1D96-4C5C-98E9-56B8460607C0Q38199152-CC879C01-9FD2-48E1-9466-D0E5CCAC6282Q38634704-4EDE8042-60B4-4DCC-81E9-EF45D5A072ECQ38767397-8B6C18E2-2215-43D8-872C-C0244F6A6B91Q38778469-0FBD3896-2A5D-4686-8A77-516C7698E4EFQ38962995-AC79FC3A-73B2-4487-A315-6C1ED0C381C9Q38988340-2F9712ED-CA71-4359-937F-733B6AFCF2BBQ39378325-67A7F617-2F19-43D0-A6E1-0ABF9E58A36CQ39405167-32505F96-FBB5-4910-8A39-F8ADB45BFE3AQ39431599-627EB7D9-3470-4D6B-87CA-D2957F76BADB
P2860
Recent development in carbohydrate-based cancer vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent development in carbohydrate-based cancer vaccines.
@en
Recent development in carbohydrate-based cancer vaccines.
@nl
type
label
Recent development in carbohydrate-based cancer vaccines.
@en
Recent development in carbohydrate-based cancer vaccines.
@nl
prefLabel
Recent development in carbohydrate-based cancer vaccines.
@en
Recent development in carbohydrate-based cancer vaccines.
@nl
P2860
P1476
Recent development in carbohydrate-based cancer vaccines.
@en
P2093
Qianli Wang
Zhongwu Guo
P2860
P304
P356
10.1016/J.CBPA.2009.08.010
P577
2009-09-18T00:00:00Z